Category:Adult
Status:Active
A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma
The purpose of this study is to assess the safety profile and antitumor activity of brentuximab vedotin administered in combination with nivolumab in patients with relapsed or refractory Hodgkin ly...
Diagnosis: Hodgkin's Lymphoma
Phase: 1 / 2
Protocol Number: 16-090
The purpose of this study is to determine whether an investigational immuno-therapy combination, nivolumab with Brentuximab vedotin compared to Brentuximab vedotin alone is safe and effective in th...
Diagnosis: Hodgkin's Lymphoma
Phase:
Protocol Number: 17-282
This study will explore whether ivabradine lowers heart rate, and thus improves exercise capacity, in survivors of lymphoma who have an elevated resting heart rate as a side effect of prior radiati...
Diagnosis: Pediatric Non-Hodgkin Lymphoma, Pediatric Hodgkin Lymphoma, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
Phase:
Protocol Number: 17-022